PDS BIOTECHNOLOGY CORP (PDSB) Stock Balance Sheet
NASDAQ:PDSB - Nasdaq - US70465T1079 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 39.98M | 41.69M | 56.56M | 73.80M | 65.20M | |||
| Other Current Assets | 2.49M | 3.36M | 2.49M | 2.70M | 1.60M | |||
| Total Current Assets | 42.47M | 45.05M | 59.06M | 76.50M | 66.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 289.10K | 304.20K | 335.00K | 500.00K | 400.00K | |||
| Other Non-Current Assets | 4.27M | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 4.56M | 304.30K | 335.00K | 500.00K | 400.00K | |||
| TOTAL ASSETS | 47.03M | 45.36M | 59.39M | 77.00M | 67.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 12.56M | 12.56M | 4.22M | 100.00K | N/A | |||
| Accrued Expenses | 2.85M | 2.84M | 2.42M | 8.50M | 2.40M | |||
| Accounts Payable | 2.86M | 1.68M | 6.98M | 1.20M | 1.30M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 18.27M | 17.09M | 13.63M | 9.80M | 3.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 6.40M | 9.27M | 19.63M | 23.20M | 0.00 | |||
| Other Non-Current Liabilities | N/A | N/A | 0.00 | 0.00 | 200.00K | |||
| Total Non-Current Liabilities | 6.40M | 9.27M | 19.63M | 23.20M | 200.00K | |||
| TOTAL LIABILITIES | 24.67M | 26.35M | 33.26M | 33.00M | 4.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -190.60M | -182.11M | -144.50M | -101.60M | -60.70M | |||
| Additional Paid In Capital | 212.95M | 201.10M | 170.62M | 145.60M | 123.90M | |||
| Common Shares | 15.00K | 12.50K | 10.90K | 0.00 | 0.00 | |||
| Shares Outstanding | 45.45M | 37.99M | 33.09M | 30.20M | 28.40M | |||
| Tangible Book Value per Share | 0.49 | 0.50 | 0.79 | 1.46 | 2.23 | |||
| Total Shareholders' Equity | 22.36M | 19.00M | 26.13M | 44.00M | 63.20M | |||
| TOTAL LIABILITIES AND EQUITY | 47.03M | 45.36M | 59.39M | 77.00M | 67.20M | |||
| Statistics | ||||||||
| Debt/Equity | 0.29 | 0.49 | 0.75 | 0.53 | N/A | |||
| Current Ratio | 2.33 | 2.64 | 4.33 | 7.81 | 17.58 | |||
| Return On Assets (ROA) | -75.48% | -82.92% | -72.31% | -53.05% | -25.18% | |||
| Return On Equity (ROE) | -158.73% | -197.90% | -164.33% | -92.84% | -26.77% | |||
All data in USD , ROIC based on taxRate of 0.21